CD44 splice variants in neurodegenerative diseases

Method for diagnosing a neurodegenerative disease

Methods of treating a tauopathy

HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIES

AUTISM-ASSOCIATED BIOMARKERS AND USES THEREOF

COVALENTLY BOUND METABOLITES AS BIOMARKERS

Modulation sAPP, sAAPα and BDNF levels in individuals diagnosed with FXS and ASD

Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment

BIOMARKER FOR NEURODEGENERATION IN NEUROLOGICAL DISEASE

BIOMARKERS FOR TANGLE-PREDOMINANT DEMENTIA

METHOD FOR DETERMINING DISEASE SEVERITY IN TAUOPATHY-RELATED NEURODEGENERATIVE DISORDERS

DRUG SCREENING PLATFORM FOR RETT SYNDROME

Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders

Methods and Compositions for Treatment of Autism

Method for diagnosing or prediagnosing a beta-amyloidopathy or an alpha-synucleopathy

BIOMARKER FOR MENTAL DISORDERS INCLUDING COGNITIVE DISORDERS, AND METHOD USING SAID BIOMARKER TO DETECT MENTAL DISORDERS INCLUDING COGNITIVE DISORDERS

Methods, systems, and devices for an invertebrate model of traumatic brain injury

MARKERS FOR ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT AND METHODS OF USING THE SAME

Methods for analyzing blood to detect diseases associated with abnormal protein aggregation

Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same

Method for detecting neurological disease associated with cognitive impairment by measuring EphA4 extracellular domain

Therapeutic applications targeting SARM1

Methods and compositions for monitoring phagocytic activity

Detection and removal of misfolded proteins/peptides

Methods and compositions for screening and treating developmental disorders

Ice-cleaved alpha-synuclein as a biomarker

Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies

Method for diagnosing and monitoring schizophrenia and tauopathies

Methods and compositions for treatment of autism

BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOF

Histone acetyltransferase activators and uses thereof

Treating neurological disorders

Diagnosis of alzheimer's disease using Aβ22(pE)-42 peptide

SYNGAP1 DYSFUNCTIONS AND USES THEREOF IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS FOR MENTAL RETARDATION

METHODS OF USING HUMAN PROTEIN KINASE C DELTA VIII AS A BIOMARKER

PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASE AND METHOD OF SCREENING THE SAME

BIOMARKERS OF AGING FOR DETECTION AND TREATMENT OF DISORDERS

Therapeutic Applications Targeting SARM1

Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies

Methods and compositions for modulating tau levels

BIOMARKER FOR NEURODEGENERATION IN NEUROLOGICAL DISEASE

TREATING NEUROLOGICAL DISORDERS

OXIDATIVE STRESS MEASUREMENT DEVICE AND RELATED METHODS

Anti-ADDL antibodies and uses thereof

AFFINITY CAPTURE OF CIRCULATING BIOMARKERS

Biomarker for psychiatric diseases including cognitive impairment and methods for detecting psychiatric diseases including cognitive impairment using the biomarkers

Protofibril selective antibodies and the use thereof

Diagnostic antibody assay

Compositions and methods for treatment of neurodegenerative diseases

Diagnostic devices and methods of use

Human anti-alpha-synuclein antibodies

PHOSPHATIDYLINOSITOL-3-KINASE P110 DELTA-TARGETED DRUGS IN THE TREATMENT OF CNS DISORDERS

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES

GAMMA-SECRETASE SUBSTRATE AND METHODS OF USE

SYNGAP1 DYSFUNCTIONS AND USES THEREOF IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS FOR MENTAL RETARDATION

Methods For Treating Clinical Conditions Associated With Lipoprotein Lipase Activity

NOVEL DIAGNOSTIC METHOD

SCREENING METHOD FOR POLYMORPHIC MARKERS IN HTRA1 GENE IN NEURODEGENERATIVE DISORDERS

Protein Aggregation Domains and Methods of Use Thereof

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES

CD44 splice variants in neurodegenerative diseases

METHODS AND KITS FOR DIAGNOSING NEURODEGENERATIVE DISEASE

Anti-ADDL antibodies and uses thereof

Model Systems and Materials for the Study and Treatment of Neurodegenerative Diseases

GAMMA-SECRETASE SUBSTRATE AND METHODS OF USE

IMMUNOTHERAPY COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF AMYLOIDOSIS

EARLY DETECTION OF COGNITION IMPAIRMENT IN ELDERLY POPULATION

MARKERS AND METHODS RELATING TO THE ASSESSMENT OF ALZHEIMER'S DISEASE

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

METHOD FOR THE IDENTIFICATION OF PATIENTS IN NEED OF THERAPY HAVING MINOR COGNITIVE DISORDERS AND THE TREATMENT OF SUCH PATIENTS

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

γ-Secretase substrates and methods of use

Methods for identifying GLP-1 secretagogues

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Molecular diagnostic method and treatment in dementia with Lewy bodies

Diagnostic agent

Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling

Anti-ADDL antibodies and uses thereof

Structure of the insulin receptor ectodomain

Indole and indoline derivatives and methods of use thereof

METHODS FOR THE TREATMENT OF DEMENTIA BASED ON APO E GENOTYPE

Anti-ADDL monoclonal antibody and use thereof

Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds

Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds

SCREENING ASSAYS FOR INHIBITORS OF BETA AMYLOID PEPTIDE ION CHANNEL FORMATION

Compounds and methods for the diagnosis and treatment of amyloid associated diseases

DIAGNOSTIC METHOD

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

DIAGNOSING NEURODEGENERATIVE DISEASES

Molecular Targets for Treatment of Learning and Memory Dysfunction

In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegenerative disorders

SCREENING METHOD FOR THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS

Development of sensitive FRET sensors and methods of using the same

GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES

A NEUROGLOBIN ENZYME-LINKED IMMUNOSORBENT ASSAY KIT AND THE USE OF IT

METHOD FOR DIAGNOSING IN VITRO OR EX VIVO PSYCHIATRIC DISORDERS AND/OR INTESTINAL DYSBIOSES

Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides

Methods for the diagnosis of dementia and other neurological disorders

Methods and compositions for the treatment of symptoms of Williams Syndrome

Use of at least one isoform of progesterone receptor membrane component 1 (PGRMC1)

Upregulation of Adamts4 Protease Activity for the Treatment of Alzheimer's Disease

METHOD OF MODULATION OF MULLERIAN INHIBITORY SUBSTANCE (MIS) RECEPTOR FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

METHODS TO IDENTIFY POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES WHICH MAY BE ASSOCIATED WITH PHYSIOLOGICAL AND MEDICAL CONDITIONS

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES

Amyloid beta receptor and uses thereof

Protofibril selective antibodies and the use thereof

Methods for Inhibiting Amyloid Precursor Protein and Beta-Amyloid Production and Accumulation

Method of Differentially Diagnosing Dementias

Biomarkers and therapeutics targets for cognitive decline

Treatment of Neurodegenerative Disorders

METHODS FOR IDENTIFYNG CELLULAR MODULATORS OF DISAGGREGATION ACTIVITY OR AGGREGATION ACTIVITY IN AN ANIMAL

PROTEIN ISOFORMS AND USES THEREOF

MICROTUBULE SYNTHESIS AS A BIOMARKER

Mouse carrying a knock-out mutation of the Qpct-gene

Biological markers for longevity and diseases and uses thereof

TREATING NEUROLOGICAL DISORDERS

Screening methods using GPR52

Truncated Fragments of Alpha-Synuclein in Lewy Body Disease

Molecular diagnostic method for dementia with lewy bodies

Method for Diagnosing Neuro-Degenerative Disease

Ppar-Gamma Agonists for Improvement of Cognitive Function in Apoe4 Negative Patients

Prevention and treatment of amyloidogenic diseases

Prevention and treatment of amyloidogenic diseases

Combination of Rosiglitazone and Donepezil for Improvement of Cognitive Function

METHODS FOR THE TREATMENT OF DEMENTIA BASED ON APO E GENOTYPE

Csf Diagnostic in Vitro Method for Diagnosis of Dementias and Neuroinflammatory Diseases

In vitro method for the diagnosis of neurodegenerative diseases

Cognitive performance with sirtuin activators

Anti-addl antibodies and uses thereof

Diagnostic Methods Of Multiple Organ Amyloidosis

Memory and learning impairments associated with disruption of Ephrin receptor A6 (EphA6) gene

METHODS TO IDENTIFY POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES WHICH MAY BE ASSOCIATED WITH PHYSIOLOGICAL AND MEDICAL CONDITIONS

Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents

P62 as a diagnostic tool for alzheimer's disease

Compounds for inhibiting beta-amyloid production and methods of identifying the compounds

Compounds for inhibiting beta-amyloid production and methods of identifying the compounds

Non-immunostimulatory antibody and compositions containing the same

Anti-ADDL monoclonal antibody and use thereof

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Compounds and methods for the diagnosis and treatment of amyloid associated diseases

Oxidative stress measurement device and related methods

Compounds for inhibiting beta-amyloid production and methods of identifying the compounds

Truncated fragments of alpha-synuclein in Lewy body disease

Compositions and methods for destabilizing lysosomes to increase oncogenic or aberrant protein degradation

Anti-ADDL antibodies and uses thereof

Compounds for inhibiting beta-amyloid production and methods of identifying the compounds

Methods for the treatment of dementia based on apo e genotype

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Method of detecting or diagnosing of a neurodegenerative disease or condition

Methods for the treatment of alzheimers disease and compositions therefore

TRIM 5 related protein as a biomarker of neurodegenerative disease

Biological markers for longevity and diseases and uses thereof

Method for increasing synaptic growth or plasticity

Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664

Methods for identifying modulators of intracellular aggregate formation

Amyloid beta-peptide and methods of use